{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:47:37Z","timestamp":1783590457394,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ando.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T21:16:37Z","timestamp":1522790197000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Quality of Life in Cushing's disease: A long term issue?"],"prefix":"10.1016","volume":"79","author":[{"given":"Susan M.","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Resmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Antonia","family":"Mart\u00ednez-Mombl\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2018.03.007_bib0210","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-17-0041","article-title":"Quality of life tools for the management of pituitary disease","volume":"177","author":"Webb","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0215","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2018.03.007_bib0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-012-0394-8","article-title":"Clinical consequences of Cushing's syndrome","volume":"15","author":"Valassi","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2018.03.007_bib0225","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-017-0735-z","article-title":"Psychiatric symptoms in patients with cushing's syndrome: prevalence, diagnosis and management","author":"Santos","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ando.2018.03.007_bib0230","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0889-8529(18)30087-2","article-title":"Cushing's syndrome from the patient perspective","volume":"23","author":"Gotch","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ando.2018.03.007_bib0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11102-016-0707-4","article-title":"The development and validation of the Leiden Bother and needs questionnaire for patients with pituitary disease: the LBNQ-Pituitary","volume":"19","author":"Andela","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2018.03.007_bib0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-16-1015","article-title":"Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial","volume":"177","author":"Andela","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0245","series-title":"Quality of life assessments in clinical trials","first-page":"16","article-title":"Quality of life studies: definitions and conceptual issues","author":"Schipper","year":"1990"},{"key":"10.1016\/j.ando.2018.03.007_bib0250","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/EJE-12-0325","article-title":"Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice","volume":"167","author":"Santos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0255","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2265.2011.04191.x","article-title":"The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties","volume":"76","author":"Milian","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.03.007_bib0260","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2265.2011.04280.x","article-title":"The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1,784 healthy people","volume":"76","author":"Milian","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.03.007_bib0265","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/EJE-15-0640","article-title":"Using subscales when scoring the Cushing's quality of life questionnaire","volume":"174","author":"Tiemensma","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0275","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000355622","article-title":"Tuebingen CD-25 is a sensitive tool to investigate health-related quality of life in Cushing's disease patients in the course of the disease","volume":"98","author":"Milian","year":"2013","journal-title":"Neuroendocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0280","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/EJE-16-0779","article-title":"Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels","volume":"176","author":"Valassi","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0290","series-title":"Cushing's disease an often misdiagnosed and not so rare disorder","first-page":"170","article-title":"Coping with Cushing's syndrome. The patients\u2019 perspectives","author":"Santos","year":"2017"},{"key":"10.1016\/j.ando.2018.03.007_bib0295","first-page":"75","article-title":"Health-related quality of life in patients with Cushing's syndrome","volume":"39","author":"Curto","year":"2014","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0300","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s11136-013-0396-7","article-title":"Mapping CushingQoL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN)","volume":"22","author":"Badia","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ando.2018.03.007_bib0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40271-013-0010-7","article-title":"Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome","volume":"6","author":"Roset","year":"2013","journal-title":"Patient"},{"key":"10.1016\/j.ando.2018.03.007_bib0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40271-013-0012-5","article-title":"Psychometric evaluation of the Cushing's Quality-of-Life questionnaire","volume":"6","author":"Nelson","year":"2013","journal-title":"Patient"},{"key":"10.1016\/j.ando.2018.03.007_bib0315","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.surg.2008.08.024","article-title":"Waiting for change: symptom resolution after adrenalectomy for Cushing's syndrome","volume":"144","author":"Sippel","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2018.03.007_bib0320","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-12-1078","article-title":"A direct comparison of quality of life in obese and Cushing's syndrome patients","volume":"168","author":"Abraham","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0325","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0330","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-14-1101","article-title":"Mechanisms in endocrinology: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies","volume":"73","author":"Andela","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0335","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-14-0371","article-title":"Small cerebellar cortex volume in patients with active Cushing's syndrome","volume":"171","author":"Santos","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0340","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.2011-2231","article-title":"Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome","volume":"97","author":"Resmini","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.03.007_bib0345","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11102-012-0425-5","article-title":"Evaluation of depression, quality of life and body image in patients with Cushing's disease","volume":"16","author":"Alcalar","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2018.03.007_bib0350","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","article-title":"Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.03.007_bib0355","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.136.2.120","article-title":"Cushing's syndrome: a psychiatric study of 29 patients","volume":"136","author":"Cohen","year":"1980","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.ando.2018.03.007_bib0360","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.03.007_bib0365","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2006.11.007","article-title":"Improvement in mood and ideation associated with increase in right caudate volume","volume":"101","author":"Starkman","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ando.2018.03.007_bib0370","first-page":"465","article-title":"Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol","volume":"48","author":"Jeffcoate","year":"1979","journal-title":"Q J Med"},{"key":"10.1016\/j.ando.2018.03.007_bib0375","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.03.007_bib0380","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-11-0307","article-title":"Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome","volume":"165","author":"Tiemensma","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0385","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/jc.2010-2490","article-title":"Coping strategies in patients after treatment for functioning or non-functioning pituitary adenomas","volume":"96","author":"Tiemensma","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.03.007_bib0390","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2018.03.007_bib0395","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The RAND 36-Item health survey 1.0","volume":"2","author":"Hays","year":"1993","journal-title":"Health Econ"},{"key":"10.1016\/j.ando.2018.03.007_bib0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-13-1013","article-title":"Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease","volume":"171","author":"Webb","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing's syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinol"},{"key":"10.1016\/j.ando.2018.03.007_bib0410","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12020-015-0737-0","article-title":"A specific nursing educational program in patients with Cushing's syndrome","volume":"53","author":"Mart\u00ednez-Mombl\u00e1n","year":"2016","journal-title":"Endocrine"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618300325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618300325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:50:54Z","timestamp":1757717454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426618300325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0003426618300325"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2018.03.007","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life in Cushing's disease: A long term issue?","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}